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Effective connectivityParkinson's disease is a common and debilitating condition, caused by aberrant activity in a complex basal
ganglia–thalamocortical circuit. Therapeutic advances rely on characterising interactions in this circuit. How-
ever, recording electrophysiological responses over the entire circuit is impractical. Dynamic causal model-
ling offers large-scale models of predictive value based on a limited or partial sampling of complex
networks. Using dynamic causalmodelling,we determined the network changes underlying the pathological ex-
cess of beta oscillations that characterise the Parkinsonian state.Wemodelled data fromﬁve patients undergoing
surgery for deep brain stimulation of more than one target. We found that connections to and from the
subthalamic nucleuswere strengthened and promoted beta synchrony, in the untreated compared to the treated
Parkinsonian state. Dynamic causal modelling was able to replicate the effects of lesioning this nucleus and may
provide a new means of directing the search for therapeutic targets.
© 2012 Elsevier Inc. All rights reserved. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Parkinson's disease (PD) is associated with abnormally synchronised
oscillations in the beta (~20 Hz) frequency band in the cortical–basal
ganglia–thalamo–cortical loop (Hammond et al., 2007; Jenkinson and
Brown, 2011; Uhlhaas and Singer, 2006). Treatment-induced reduction
in the amplitude of these oscillations correlates withmotor improve-
ment (Jenkinson and Brown, 2011). Conversely, the artiﬁcial induc-
tion of beta oscillations slows movement in patients with PD (Chen
et al., 2011; Eusebio et al., 2008) and healthy subjects (Pogosyan et
al., 2009), and exacerbates Parkinsonian behaviour in rodents
(Gradinaru et al., 2009). These observations suggest that high levels
of beta activity could be mechanistically related to Parkinsonian
motor impairments, or, at the very least, provide a faithful biomarker
of the Parkinsonian state. Thus the network changes that underpin
this activity may be highly informative about the pathophysiology
of the disease and help direct the search for new treatment targets.
Yet, one of the major challenges in neurobiology is characterising
dynamic interactions in complex and distributed networks – such as
the cortical–basal ganglia–thalamo–cortical loop – that can only besal modelling; DBS, deep brain
Pallidus externa; GPi, Globus
ial; LFP, local ﬁeld potential;
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n).
rights reserved. This is an open accpartially sampled. Dynamic causal models (DCMs) allow electrophysio-
logical data to be ﬁtted by biologically plausible (conductance-based),
neural-massmodels of coupled sources (Moran et al., 2009). Important-
ly, complex models of neural circuits can be identiﬁed using data from
just a subset of the components of these circuits (Moran et al., 2011).
Crucially, inferences can still be made about the remaining circuit com-
ponents, based on the inﬂuence they exert on the observed compo-
nents. The importance of this novel modelling approach lies in the
potential to identify new therapeutic targets and explore the effects of
any interventions in silico. Here, we develop a DCMbased on exception-
al archival data from a group of PD patients who underwent simulta-
neous implantation of deep brain stimulation (DBS) electrodes into
the Globus Pallidus interna (GPi) and the subthalamic nucleus (STN)
and recording of electroencephalographic activity (EEG). Recordings
were made both OFF and ON the dopaminergic prodrug, levodopa, to
determine the key network differences between these states.
Material and methods
Patients
The patients gave informed consent to take part in the study, which
was approved by the Ethical Committee of the CTO “A. Alesini”Hospital.
All ﬁve patients (mean age of 50 years; range of 37–64 years; two fe-
males; mean duration of disease, 14 years; range of 9–24 years) were
enrolled in a trial of combined pallidal and subthalamic DBS (Peppe et
al., 2004). Their mean United Parkinson's Disease Rating Scale
(UPDRS) motor scores were 66 (range of 48–80) and 13 (range of
7–20) off and on medication, respectively. Patients took a mean dailyess article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
302 A.C. Marreiros et al. / NeuroImage 66 (2013) 301–310dosage of 950 mg of levodopa (range of 150–1500 mg). LFP features
have been previously reported in all but one patient (Brown et al.,
2001; Cassidy et al., 2002; Fogelson et al., 2005; Williams et al., 2002).
The operative procedure has been described previously (Brown et
al., 2001; Peppe et al., 2004). Macroelectrodes were inserted after GPi
and STN had been identiﬁed by non-telemetric ventriculography and
localised using microelectrode recording and microstimulation whilst
the subject was awake. The coordinates at the tip of contact 0 were
19–24 mm from the midline of the patient, 2 mm in front of the
mid-commissural point, and 6 mm below the anterior commissure
(AC)–posterior commissure (PC) line for GPi, and 12 mm from themid-
line, 0 mm from the mid-commissural point, and 4–5 mm below the
AC–PC line for STN. Macroelectrode position was conﬁrmed postopera-
tively using magnetic resonance imaging (MRI) or computerised to-
mography superimposed on pre‐operative MRI using image fusion
systems. The DBS electrodes in the pallidum and STN were models
3387 and 3389 (Medtronic Neurological Division, Minneapolis, MN)
with four platinum–iridium cylindrical surfaces. Contact 0 was the
most caudal, and contact 3 was the most rostral.
Electrophysiological recordings
Electrophysiological recordings were made 3–6 days postopera-
tively, in the interval between DBS electrode implantation and sub-
sequent connection to a subcutaneous stimulator. Recordings were
acquired whilst the patients were seated on a bed in a resting,
awake state and both following overnight withdrawal of anti-
parkinsonian medication and about 1 h after 200 mg levodopa ad-
ministration. Deep brain activity was recorded bipolarly from the
adjacent four contacts of each DBS electrode (0–1, 1–2, and 2–3).
EEG activity was recorded bipolarly from a single pair of EEG elec-
trodes, either Cz–Fz or Cz–FCz (2 cases) using 9 mm silver/silver
chloride electrodes or needle electrodes (3 cases). The ground was
placed on a shoulder. Signals were ampliﬁed and pass band ﬁltered
between 1 and 300 Hz using a Nicolet Viking IIe and data captured
through an A-D card (PCM-DAS12, ComputerBoards, Middleboro,
MA 02346, USA) onto a portable computer using custom-written
software. Signals were sampled at 1 kHz.
Dynamic causal modelling for steady state responses
DCM provides a generic framework to infer the biophysical
causes of neuroimaging data (Marreiros et al., 2010). Unlike func-
tional connectivity measures such as correlations or coherence,
which examine the statistical dependencies of time series data,
DCM uses a generative or forward model to allow inferences about
the underlying mechanisms behind the observations; that is, direct-
ed effective connectivity — a model based characterisation of causal
inﬂuences. In the general case, DCMs describe how experimental
manipulations (u) inﬂuence the dynamics of hidden (neuronal)
states of the system (x), using the state evolution equation
_x ¼ f x tð Þ;u tð Þ; θð Þ, where x is the rate of change of the system's states
x, f summarises the biophysical mechanisms underlying the tempo-
ral evolution of x, and θ is a set of unknown evolution parameters.
DCMs map the system's hidden states (x) to experimental measures
(y), typically written as the following static observation equation
y=g(x,φ) where g is the instantaneous mapping from system states
to observations and φ is a set of unknown observation parameters.
Here, we use a DCM for steady state responses (SSR), which uses a
generative model of a distributed network of interacting neuronal
sources to predict observant spectral densities (Moran et al., 2009).
The dynamics of these sources are speciﬁed by a set of ﬁrst-order dif-
ferential equations (Moran et al., 2011). DCM for SSR models the ac-
tivity of a source with a neural mass model, which ascribes one or
more subpopulations to each source (Supplemental Fig. S1). The ac-
tivity of subpopulations are modelled with hidden neuronal states(ensemble depolarisation and ﬁring rates), whose dynamics depend
on intrinsic parameters that encode the amplitude of post synaptic
responses and synaptic rate constants. The ensemble ﬁring of one
population drives the averagemembrane potential of others through
either glutamate (which produces postsynaptic depolarisation) or
GABA (hyperpolarisation) as a neurotransmitter. These effects are
mediated by a postsynaptic (alpha) kernel that is either positive or
negative. The (excitatory or inhibitory) inﬂuence of one subpopula-
tion on another is parameterised by extrinsic effective connectivity
(between sources) or intrinsic connectivity (within sources). Effec-
tive connectivity is modelled as a gain factor that couples discharge
rates in one subpopulation to depolarisation in another. The model's
architecture (see below) was identical to that used by us in our pre-
vious study in the 6-hydroxy-dopamine (6OHDA) midbrain lesioned
rodent model of Parkinsonism (Moran et al., 2011). Three (layered)
populations were used to model the cortical source (Moran et al.,
2009), and a single population of neurons, either glutamatergic (ex-
citatory) or GABAergic (inhibitory) was used for BG nuclei (Fig. 2).
The model's prior values are provided in Supplemental Table 1. Dur-
ing Bayesian model inversion, these parameters are estimated in
terms of posterior probability densities — summarised with their
conditional mean and covariance (Supplemental Fig. S6). The poste-
rior or conditional means of the connectivity and synaptic parame-
ters are the most likely given the data (see Supplemental material
for further information on DCM for SSR). In the present analysis, all
the neural mass model parameters (Supplemental Table 1) were
the same for the two conditions, ON and OFF levodopa, and the effect
of levodopa was modelled by changes in the strength of extrinsic
connections. Therefore, differences in observed spectral proﬁles
were explained in terms of coupling changes amongst the nodes of
the underlying network model, with a gain of more or less than
one representing an increase or decrease, respectively, in connection
strength.
Model structure
The DCM was based on the motor cortico–basal ganglia–
thalamo–cortical loop (Fig. 2). The connections were based on the
well characterised re-entrant circuits linking the cortex, basal
ganglia and thalamus, where the main features of this network in-
clude the so-called ‘direct’, ‘indirect’ and ‘hyperdirect’ pathways
(Nambu, 2004; Smith et al., 1998). The cortex was modelled by a
three layer cell ensemble which includes excitatory spiny stellate
cells, projection (pyramidal) glutamatergic cells and inhibitory
GABAergic interneurons. Excitatory projections from cortex inner-
vate the striatum, and STN (the hyperdirect pathway). The striatum
comprises an inhibitory cell mass that projects to other inhibitory
cell masses, the GPe (indirect pathway) and GPi (direct pathway).
The GPe is reciprocally connected to the excitatory cell mass of the
STN (Bevan et al., 2002a,b). STN projects to GPi, which in turn pro-
jects (through another extrinsic connection) to the thalamus. The
thalamus, which excites cortex, is itself inhibited by GPi. The major
glutamatergic and GABAergic connections between six key compo-
nents of the cortico–basal ganglia–thalamocortical circuit were
thus incorporated into our standard model architecture (Smith et
al., 1998). In particular, we included the two elements that have
been promoted as crucial for the expression of exaggerated beta os-
cillations in Parkinsonism; the hyperdirect pathway (Gradinaru et
al., 2009; Magill et al., 2001) and the reciprocal STN–GPe network
(Cruz et al., 2011; Holgado et al., 2010). The effects of the experimen-
tal conditions, ON and OFF levodopa, were explained by the same
model through changes in the extrinsic connections in the network.
Although our standard model does not include all known connec-
tions, the addition of more connections does not necessarily improve
the ability of the loop circuit to sustain beta oscillations (see compar-
ison with other model architectures in the results).
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The data used in this model were scalp EEG and LFPs from DBS
electrodes in STN and GPi. The remaining areas were modelled as
hidden sources. Note that by using DCMs, inferences can still be
made about the parameters of hidden sources based on the inﬂuence
they exert on nodes from which recordings are made. In fact, mathe-
matically, all the parameters of a DCM are hidden or latent and the
full dataset serves to optimise all of the parameters of the model.
Brain activity recordings from cortex, STN and GPi were taken from
the continuous time domain data. Principal component analysis (PCA)
of multiple contacts in a single source or site was performed before
spectral decomposition to reveal the internal structure of the data (e.g.
from the three bipolar channels per site). PCA uses an orthogonal trans-
formation (generally a singular value decomposition— SVD) to convert a
set of observations of possibly correlated contacts into a set of values of
uncorrelated variables which capture the greatest amount of variance
expressed over time. These are called principal components. The ﬁrst
principal components, which account for as much of the variability in
each data set as possible, were taken as the representative of the signals
in GPi and STN. Frequency domain representations of LFP and EEGwere
constructed from the principle components and recorded time series,
respectively using a vector auto regression (VAR) model of order p=8.
Speciﬁcally, channel data y, from the three channels (Cortex, STN and
GPi) were modelled as an AR process.
yn ¼ A 1ð Þyn−1 þ A 2ð Þyn−2…þ A pð Þyn−p þ e
Note that principal component analysis produced a principle
eigenvariate that was dominated by a single peak within the frequency
band of interest. Themodel order, p, determines the number of peaks in
the associated spectra, and our selection of p=8 adequately accommo-
dated these spectra, affording robust and smooth spectral features. In
selecting a model order of 8 we reprised the model order used in a
DCM analysis of LFP data from the lateral nucleus of the amygdala and
the dorsal hippocampus (Moran et al., 2009), this order also gave the
best results across the patient data.We also tried p=14, but this tended
to produce spectra in which the dominant peak was often divided in
two. Model ﬁts were slightly worse in this case. Frequency splitting
(the appearance of a spurious spectral peak) is a recognised problem
with AR methods when the model order is too high (Spyers-Ashby et
al., 1998).
Both the autoregressive coefﬁcientsA pð Þ∈R33 and channel noise
covariance Eij were estimated using the spectral toolbox in SPM
(http://www.ﬁl.ion.ucl.ac.uk) which allows for Bayesian point esti-
mators. This entails a variational approach that estimates the ap-
proximated posterior densities in terms of conditional mean and
covariance. These moments are optimised through hyperparameters
encoding the precision of the innovations and the prior precision of
the autoregressive parameters per se (Moran et al., 2009). The
autoregressive coefﬁcients and estimated channel noise covariance
then provided a direct estimate of the cross-spectral densities,
using the following transform:
Hij ωð Þ ¼
1
A 1ð Þij e
iw þ A 2ð Þij ei2w þ :::::: þ A
pð Þ
ij e
ipw
gij ωð Þc ¼ H ωð ÞijEijH ωð Þij
We focused on the frequency window from 13 to 35 Hz as this is
the frequency band that has been most clearly implicated in Parkin-
sonism in both correlative (Jenkinson and Brown, 2011) and causality
(Chen et al., 2011; Eusebio et al., 2008; Gradinaru et al., 2009) studies.Results
Spectral density model ﬁts
We examined the frequency or spectral responses using resting
state data from patients OFF and ON levodopa. Three segments, each
of mean 50.6±(SEM) 2.4 s duration, were assessed for each drug
state per patient. We used principal component analysis (PCA) to sum-
marise the signals from the three bipolar contact pairs of each electrode
in the STNandGPi and isolated theﬁrst component,which explained on
average 74.4±0.6% of the variance. A vector autoregressive model re-
vealed a peak in power spectra over the beta 13–35 Hz band in both
group-averaged EEG and in averages of the principal component of
depth recordings from each site OFF levodopa across all patients (see
Fig. 1A). These peaks were attenuated ON levodopa (Fig. 1B), as con-
ﬁrmed by a one-way ANOVA; with averaged beta activity pooled over
auto and cross-spectra ON and OFF medication as a factor (F(1,23)=
14.15, p=0.0011). Beta activity was pooled over auto and cross-
spectra by way of data reduction prior to this ANOVA, but separate
contrasts of ON and OFF for pooled auto-spectra (F(1,23)=12.45, p=
0.0019) andpooled cross-spectra (F(1,23)=11.43, p=0.0027) afforded
similar results. When auto-spectra were broken down still further to
individual sites, only those for STN were signiﬁcantly different between
ON and OFF (F(1,23)=34.28, pb0.0001). Similarly, when cross-spectra
were considered individually, only that for STN–GPi differed signiﬁ-
cantly between ON and OFF (F(1,23)=15.21, p=0.0008).
ON and OFF medication data segments were then paired and their
cross-spectral densities were modelled using the DCM illustrated in
Fig. 2. This was repeated for each of three segment pairs per patient.
Model ﬁtting or inversion entails estimating the mean and variance of
unknown model parameters using the spectral density data-features
(see Supplemental material for further information on Bayesian model
inversion and comparison). These unknown parameters include the
biophysical parameters of the neural-mass model aswell as parameters
controlling the spectral composition of neuronal and channel noise.
DCM ﬁtted each pair of segments together, and only the strengths of
the extrinsic (between-source) connections were allowed to change
to account for the inﬂuence of levodopa. Supplemental Fig. 2 shows
the model evidence across the three paired segments per patient of
ON and OFF data. The overall ﬁt (accuracy) of the DCM was consistent
for all but three segment pairs, which were precluded from subsequent
analysis (Supplemental Fig. 2). This left 12 pairs (with at least one from
each subject). Model data were averaged from these 12 segment pairs
to give the group mean model data (Fig. 1). Original data and model
auto and cross spectra corresponded well for both ON (Fig. 1A) and
OFF (Fig. 1B) levodopa states.
Changes in effective connectivity between states
The differences betweenONandOFF levodopa statesweremodelled
through themodulation of all extrinsic connections in the network. The
connectivitymaximuma posteriori (MAP) estimates for the 12 segments
were combined and averaged over the group. Group differences be-
tween MAP (connectivity strength) estimates ON and OFF levodopa
are illustrated in Fig. 3A for the nine extrinsic network connections.
These were obtained through a simple average of the conditional
means and their conﬁdence intervals. Effective connectivity could in-
crease or decrease; therefore, we deﬁned signiﬁcant changes as those
in which [i] there was a 95% conﬁdence about changes at the group
level (with >95% of the posterior mass OFF being above or below the
level ON) and [ii] these changes were signiﬁcant in at least 50% of the
12 individual segment pairs (Fig. 3B). The latter criterionwas important
as there was some variability in the spectral proﬁles and ensuing MAP
estimates amongst the segment pairs. Some of this variability arose at
the subject level and might relate to slight differences in surgical
targeting, surgical stun effects or clinical phenotype. The variability
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Fig. 1. Model ﬁt to recorded data. (A,B) Averaged auto-spectral and cross-spectral densities from cortex, subthalamic nucleus (STN) and Globus Pallidus internal (GPi) over
13–35 Hz (evaluated using a vector autoregressive model) ON (A) and OFF levodopa (B). Spectral responses averaged across the 12 data segment pairs from the ﬁve patients
are plotted as dotted lines, whilst the 95% conﬁdence intervals (CI) of the corresponding DCM predictions are shown as a shaded area. The main diagonal displays the
auto-spectral densities at each site and the off-diagonal elements shows the cross spectra. All empirical spectra fall inside the shaded areas and indicate an overall good model ﬁt.
304 A.C. Marreiros et al. / NeuroImage 66 (2013) 301–310between samples from the same subject might relate to slightly differ-
ent levels of arousal at rest (see Suppplementary Results;Model validity
and reproducibility). Under these criteria, the connections from GPe
(Globus Pallidus externa) to STN (part of the indirect pathway), cortex
to STN (hyperdirect pathway) and STN to GPi increased fromON to OFF
levodopa. In order to preclude identiﬁability issues, we examined the
posterior correlations amongst parameters from all DCMs. When high
dependencies exist between two parameters, a change in either could
account for the same differences in the data features. However, only
small conditional correlations (0.06±0.01) were observed amongst
changes in extrinsic connectivity (Supplemental Fig. S5). Our model
also produced well-behaved posterior densities, when compared to
the equivalent prior densities (Supplemental Fig. S6).
Comparison with other model architectures
Our model architecture did not include all known connections.
However, the addition of more connections might not necessarily
improve the ability of the basal ganglia cortical circuit (and model)
to generate beta oscillations. To address this issue, we tried adding
two less well-studied, but potentially important, pallidofugal con-
nections, either from GPe to GPi or from GPe to striatum (Bevan et
al., 1998) and evaluated the evidence for these extra connections
using Bayesian model comparison. Bayesian model comparison
uses the (variational free energy approximation to) model evidence to
compare competing hypotheses about the neural architecture generat-
ing data. For each of the 12 paired segments, we inverted or ﬁtted the
data using models with extra connections. In line with our previous
ﬁndings in the Parkinsonian rodent (Moran et al., 2011), the additionof either connection did not increase model evidence, in relation to
the standard model (Stephan et al., 2009). In addition, we tested a fur-
ther model which comprised the “standard” architecture but in which
we assumed that the signal ascribed to the GPi was actually derived
from a source in GPe. This model was considered because (even with
an optimally placed DBS electrode) the upper bipolar contact pair
could sample theGPe rather than the GPi. Thismodel performed poorly,
consistent with our initial supposition that the pallidal signals arose
from a GPi source. Fig. 4 conﬁrms the strong evidence in favour of our
original model (the standard model—Model 1). The Bayes Factor com-
paring the ﬁrst two models was (BF1,2)>>150. This corresponds to a
>>99% probability that the standard model was the most likely given
our data (see Supplemental material for further information on Bayes-
ian model inversion and comparison). We conclude that the model ar-
chitecture described in Fig. 2 provided the best balance of accuracy
and complexity for our given data set. Having established the adequacy
of the basicmodel, we next quantiﬁed the contribution of different con-
nections to the generation of beta activity:
Contribution analysis
We used the MAP estimates from our optimised DCMs above to in-
vestigate which connections promoted or attenuated beta-activity in
the patients. Our goal was to see if particular connections contributed
more to beta activity than others. We therefore quantiﬁed the degree
to which a change in a coupling parameter, c, affected beta band oscilla-
tory activity, β, throughout the circuit (Moran et al., 2011). The deriva-
tive, dβ/dc, was computed for beta responses (over a range of
frequencies) at each source and averaged to create a measure of
Glutamatergic stellate cells
GABAergic cells
Glutamatergic Projection cells 
Data (LFP/EEG recordings)
1.  Cortex 
2.  Striatum 
3.  External
globus
pallidus
(GPe)
4. Subthalamic
Nucleus
(STN)
6. Thalamus
5.  Internal globus
pallidus
(GPi)
Fig. 2. The dynamic causal model. The DCM comprised the principal nodes and connections in the human motor cortico-basal ganglia-thalamocortical loop: the nodes included
motor cortex, modelled by a three layer cell ensemble comprising input, excitatory spiny stellate cells, projection (pyramidal) glutamatergic cells and inhibitory GABAergic inter-
neurons. Excitatory projections from cortex innervated the Striatum, and STN (the hyperdirect pathway). The striatum comprised an inhibitory cell mass that projected to two other
inhibitory cell masses, GPe (as part of the indirect pathway), and GPi (via the direct pathway). The GPe and STN expressed reciprocal connections, and signals from the hyperdirect
and indirect pathways were conveyed via excitatory STN projections to the GPi. The thalamus, which excited the cortex, was itself inhibited by connections from GPi. Data, D, used
for the model inversion were acquired from recordings in cortex, STN and GPi. For model parameter's prior values see Supplemental Table 1.
305A.C. Marreiros et al. / NeuroImage 66 (2013) 301–310distributed beta-contribution for each connection. Fig. 5 shows the re-
sults of this contribution analysis (Fig. 5A) and statistical signiﬁcance
(Fig. 5B) of the differences in contribution ON and OFF levodopa, over
the 12 segment pairs.Wilcoxon signed-rank tests across the contribution
spectra revealed signiﬁcantly (pb0.01) different effects of contribution
between theONandOFF levodopa states for four key connections: cortex
to STN, STN to GPi, STN to GPe and GPe to STN. For all of these-1
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which beta activity was promoted in the OFF compared to the ON
levodopa state. Interestingly, these connections included the three with
the greatest increases in effective connectivity in the OFF levodopa
state (Fig. 3A) andwere all linked to the STN. This suggests that increases
in the connections linking STNwith other regions are particularly impor-
tant in exacerbating beta oscillations in our patients.ST
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Fig. 4. Bayesianmodel comparison. Fixed effectmodel comparison using data from all ﬁve
patients, ON and OFF levodopa. Model 1 comprised the “standard” basal–ganglia–
thalamocortical re-entrant circuit shown in Fig. 2. Model 2 included a new connection
from GPe to GPi, whilst model 3 included a new connection from GPe to striatum.
Model 4 comprised the “standard” architecture but with the data recorded from the elec-
trode presumed to be in GPi now assigned to a source in GPe. All models are compared to
Model 4. There is very strong evidence in favour of Model 1 — the standard model.
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STN lesions ameliorate Parkinsonism and suppress beta activity
(Chen et al., 2006). Thus to test the face validity of our model, we
simulated a STN lesion by setting the strengths of the connections
to and from the STN to zero, and also by removing the STN source
from the model altogether. The effects were identical, namely aHz
dB
/d
c
GPi to Thalamus
10 20 30 40
0
2
4
6
8
10
12
14
Hz
dB
/d
c
Thalamus to Cortex
10 20 30 40
0
2
4
6
8
10
12
14
Hz
dB
/d
c
Cortex to Striatum
10 20 30 40
0
2
4
6
8
10
12
14
Hz
dB
/d
c
Cortex to STN
10 20 30 40
0
2
4
6
8
10
12
14
Hz
dB
/d
c
Striatum to GPe
10 20 30 40
0
2
4
6
8
10
12
14
Hz
dB
/d
c
Striatum to GPi
10 20 30 40
0
2
4
6
8
10
12
14
Hz
dB
/d
c
STN to GPi
10 20 30 40
0
2
4
6
8
10
12
14
Hz
dB
/d
c
STN to GPe
10 20 30 40
0
2
4
6
8
10
12
14
Hz
dB
/d
c
GPe to STN
10 20 30 40
0
2
4
6
8
10
12
14
BA
Fig. 5. Contribution analysis. (A) Median contribution analysis for the spectral responses (a
ON (blue) and OFF (red) levodopa. Respective lower and upper quartiles of the contribution
increases in the respective connectivity strength produced higher beta activity in the Parkin
ative to OFF levodopa. Beta promoting potency was greater OFF than ON for four connection
izontal lines in (B)).profound attenuation of beta activity exhibited by the circuit
(Fig. 6). We also explored the effects of separately setting each con-
nection strength to and from STN to their respective ON levodopa
values, whilst leaving all other connections with their OFF drug
strengths (Supplemental Fig. S7). Even such partial lesioning of the
GPe–STN and STN–GPe connections was sufﬁcient to profoundly at-
tenuate beta activity. Although partial lesioning of the CTX–STN
and STN–GPi connections also attenuated circuit beta activity,
these changes did not reach signiﬁcance at the group (sample)
level. Complete lesioning of these connections did, however, achieve
signiﬁcant attenuation of beta activity in the system (Supplemental
Fig. S7).
Discussion
Classical models of connectivity within the cortico–basal ganglia–
thalamocortical circuit explain PD symptoms in terms of altered ﬁr-
ing rates along the direct/indirect pathways (DeLong, 1990). More
recent research has highlighted the role of pathological oscillatory
synchronisation in the Parkinsonian state, particularly that in the
beta frequency band (Hammond et al., 2007; Jenkinson and Brown,
2011; Uhlhaas and Singer, 2006). Our understanding builds on this
through dynamic causal modelling of LFPs and EEG, which, in order
to be detected, necessitate spatiotemporal summation and hence,
synchronisation of activity, across local neuronal elements. Using
neural mass models that embody ensemble ﬁring output and mem-
brane potential inputs, our model generated spectral activity pat-
terns (that characterise PD patients OFF and ON medication) inHz
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Fig. 6. Lesion analysis. (A) Effect of lesioning all connections to and from STN on net beta activity in the Parkinsonian network (red—without lesion: blue—with lesion). The shaded
areas correspond to lower and upper quartiles of the contribution results from the 12 DCM. (B) Wilcoxon signed-rank test of the effects on lesioning: beta activity was profoundly
and signiﬁcantly suppressed. Horizontal red line denotes pb0.01. Results were identical if the population of STN neurons was removed from the model.
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nodes in the cortico–basal ganglia–thalamocortical circuit. Speciﬁ-
cally, patients OFF medication had increased input to the STN via
the hyperdirect pathway and from the GPe, as well as a strengthen-
ing of projections from the STN to the GPi. These connections, to-
gether with those from STN to GPe, also promoted beta oscillations
within the network reconﬁgured by diminished tonic dopaminergic
activity.
Model architecture
Our model architecture, like others, represents an informed reduc-
tion of complex biological connectivity, and as such might not be the
only architecture that can sustain exaggerated beta oscillations. How-
ever, our model does incorporate the major glutamatergic and
GABAergic connections between the six key components of the cir-
cuit, thus capturing the core elements of the direct, indirect and
hyperdirect pathways and placing it within established frameworks.
Moreover, our standard model was sufﬁcient to explain the pattern
of beta activity recorded in the ON and OFF drug states and performed
better than two more complex models in ﬁtting two very different
data sets; one from the Parkinsonian patients reported here and one
from anaesthetised Parkinsonian rodents (Moran et al., 2011). Crucially,
ourmodel was also successful inmaking valid predictions regarding the
consequence of lesions of the subthalamic nucleus and its connections.
Lesioning, micro-lesioning or muscimol inactivation of this nucleus re-
duces beta oscillations and improves Parkinsonism in primates, includ-
ing humans (Chen et al., 2006; Tachibana et al., 2011).
Changes in connection strength between ON and OFF drug states
We found signiﬁcant and relatively consistent differences in
effective connectivity between the treated and untreated Parkinso-
nian states. First, the effective connection strength of the cortical
‘hyperdirect’ input to the STN was increased in the OFF state. Such
a strengthening of the hyperdirect pathway in the OFF drug state
would be consistent with recent fMRI ﬁndings in patients with PD
(Baudrexel et al., 2011). It would also be in accord with experimental
studies in the Parkinsonian rodent (Dejean et al., 2008; Magill et al.,
2001) and reprises the critical role of the glutamatergic hyperdirect
pathway in other models of PD (Holgado et al., 2010; Leblois et al.,
2006). In addition, our previous DCM study (Moran et al., 2011) identi-
ﬁed the hyperdirect pathway as strengthened in the Parkinsonian ro-
dent, but as we contrasted healthy rodents with Parkinsonian animals
treated with 6OHDA, we were unable to ask whether this represented
an acutely reversible change in the hyperdirect pathway or a ﬁxedconsequence of chronic plasticity. The present ﬁndings conﬁrm that
the strengthening of the hyperdirect pathway in the Parkinsonian
state is reversible by treatment with the dopamine prodrug, levodopa.
This too ﬁnds a precedent; synaptic release of glutamate (and GABA)
are suppressed by the activation of presynaptic D2 dopamine receptors
in the STN (Baufreton and Bevan, 2008; Cragg et al., 2004; Shen and
Johnson, 2000) and in experimental PD AMPA (and GABA) receptor
agonists generate larger currents in postsynaptic STN neurons (Shen
and Johnson, 2005).
Second, the GPe–STN connection was strengthened in the OFF state,
consistent with the key role of over-activity in the indirect pathway in
PD (Bergman et al., 1990; Kravitz et al., 2010). The loss of dopamine
in the STN in PD may amplify GABAergic feedback inhibition from the
GP (Cragg et al., 2004; Shen and Johnson, 2000, 2005). IPSPs due to
GPe input are necessary to relieve the inactivation of Nav channels dur-
ing autonomous activity in the STN (Baufreton and Bevan, 2008), and
may even promote rebound bursts by bringing themembrane potential
to a more hyperpolarised state, which primes low-threshold calcium
channels (Bevan et al., 2000). The interaction of increased GPe inhibi-
tion with autonomous pacemaker activity in STN is able to generate
spontaneous oscillations at sub-beta frequencies in vitro (Baufreton et
al., 2005; Bevan et al., 2002a,b; Plenz and Kital, 1999). In vivo, it has
been proposed that the same increased GPe inhibition acts to potentiate
cortically driven higher frequency oscillations in the STN (Baufreton et
al., 2005), or, in the setting of tonic excitation of the STN by the cortex,
enables the STN–GPe circuit to oscillate at higher frequencies (Holgado
et al., 2010; Kumar et al., 2011). Hence the blockade of glutamatergic in-
puts from cerebral cortex (and thalamus) in the STN suppresses beta ac-
tivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
treated primate (Tachibana et al., 2011).
Effects of manipulating connection strengths
However, simple contrasts of the steady-state networks describing
patients OFF and ON levodopa need not necessarily capture the func-
tional signiﬁcance of all connections in the OFF state. This is because
connections might have profound inﬂuence upon abnormal activity in
the re-organised ‘OFF’ circuit, even though their connection strengths
might remain relatively unchanged between ON and OFF states. It is
also important to clarify whether increases in effective connectivity
are pathological and promote beta synchronisation or are secondary
compensatory phenomena acting to counterbalance excessive beta
synchrony. Contribution analysis can identify those connections
whose beta promoting potency is much greater when embedded in
the ‘OFF’ network. In our work, the tendency to promote beta activity
was quantiﬁed by the derivative dβ/dc in response to small changes
308 A.C. Marreiros et al. / NeuroImage 66 (2013) 301–310in connection strength. Small changes have the advantage that they are
more likely to be assimilated within the circuit without reconﬁguration
to a new steady-state. This approach revealed that all three connections
that are increased in theOFF state are also promoting beta synchrony, as
did the connection from STN to GPe in the OFF state circuit. This sug-
gests that the strengthening of the three connections is primarily path-
ological and not compensatory. In addition, the reciprocal connections
between GPe to STN emerge as having a particularly important role in
promoting beta synchrony in the ‘OFF’ compared to the ‘ON’ state cir-
cuit. The critical role of the GPe-STN circuit in maintaining beta is
supported by previous modelling (Holgado et al., 2010; Kumar et al.,
2011), recent experiments in 6OHDA midbrain lesioned rodents
(Mallet et al., 2008a,b) and MPTP treated primates (Tachibana et al.,
2011). In the latter instance, separate inactivation of the GPe and STN
with muscimol was sufﬁcient to suppress beta oscillations. The in-
creased beta promoting effects of the STN-GPe and STN to GPi connec-
tions in the OFF state may relate to dopamine's D2/3-like presynaptic
and D4-like post-synaptic receptors in the pallidum, which act to re-
duce excitatory input (Hernández et al., 2006), in combination with
the functional effects on inhibitory input in the STN noted earlier.
With a rich recurrent architecture there may be several potential
mechanisms for generating beta oscillations. One striking aspect of
our results is the relatively modest role of connections to and from the
striatum, especially given the ﬂorid dopaminergic denervation of the
striatum in PD. Some modelling studies have emphasised the roles of
the striatum and direct and indirect pathways (Gittis et al., 2011;
Kumar et al., 2011; Leblois et al., 2006; McCarthy et al., 2011), although
only those implicating the striatum and indirect pathway explicitly fo-
cussed on beta synchrony. The results of experimental studies have
been rather variable. For example, a recent investigation in MPTP treat-
ed primates found that microinjection of gabazine into the GPe to block
GABAergic inputs from the striatum failed to change beta in the GPe
(Tachibana et al., 2011). In contrast, direct infusion of the cholinergic
agonist carbachol into the striatum of otherwise healthy mice is able
to induce prominent beta frequency oscillations in the striatal LFP
(McCarthy et al., 2011). But rather than contest the importance of dif-
ferent elements in promoting beta oscillations, it seems reasonable to
acknowledge that many interventionsmay have the potential tomodu-
late beta synchrony; the issue iswhether they reﬂect those changes that
support beta oscillations in the disease state. In this regard, the results
reported here are likely to be particularly relevant as our DCM was
constrained to ﬁt the pattern of synchronisation across nodes expressed
in a comprehensive set of simultaneously acquired signals in patients
with PD. This is not to say that even those elements that do not, in prac-
tice, contribute to beta synchrony are irrelevant, for they may well be
important in modulating discharge rate, bursting and synchronisation
at other frequencies.
Finally, we tested the face validity of our model by mimicking the
effects of a STN lesion, and conﬁrmed our expectation that this would
attenuate beta activity across the basal ganglia–thalamocortical sys-
tem (Chen et al., 2006). In addition, we explored the importance of
each connection to and from the STN. Simply resetting the strength
of either the GPe–STN or STN–GPe connections to their respective
ON levodopa values, whilst leaving all other connections with their
OFF drug strengths was sufﬁcient to profoundly attenuate beta activ-
ity, underscoring the importance of the STN–GPe recurrent circuit in
sustaining beta oscillations. The hyperdirect CTX–STN and the STN–
GPi connections were also important in sustaining beta oscillations,
although these connections had to be lesioned in order to achieve sig-
niﬁcant attenuation of beta activity in the system (Supplemental
Fig. S7). The implication here is that although the STN–GPe recurrent
circuit may be an essential resonator in the Parkinsonian system, it is
not by itself sufﬁcient to drive the exaggerated beta state; cortical activ-
ity is necessary as a substrate to be ampliﬁed or as a tonic input tomain-
tain the STN–GPe circuit in a resonating mode (Holgado et al., 2010).
Likewise, the dependency on the hyperdirect pathway rules out theSTN per se as the beta generator. Indeed, even if STN–GPewasmodelled
using three interconnected subpopulations similar to the cortex (to ex-
plicitly provide a subcortical structure potentially capable of generating
oscillations), it was still dependant on cortical input and in the absence
of this input it was not able to generate the beta oscillations.
Comparison with DCM in the 6OHDA midbrain lesioned rodent
Some of the major ﬁndings in the patients accord with those of our
previous DCM study in Parkinsonian rodents (Moran et al., 2011).
Both demonstrated strengthening of the hyperdirect pathway in the
Parkinsonian state and increased beta promoting potency in the GPe
to STN pathway. Differences did however exist (Supplemental Table
2). Indeed, it would have been surprising if there had not been somedif-
ferences between the patient and rodent models, as they are based on
data from different species and impairments underscored by progres-
sive degeneration and acute toxicity, respectively. In particular, the
treated Parkinsonian patient and healthy rodent cannot be considered
strictly homologous. There are a number of important plastic changes
that occur secondary to chronic dopaminergic cell loss that might
have been apparent in a comparison between healthy and Parkinsonian
animals, but not in one between Parkinsonian patients differing only in
their treatment state (Surmeier et al., 2010). Conversely, plastic changes
may also occur due to chronic intermittent dopaminergic therapy in pa-
tients that would be absent in the untreated Parkinsonian rodent
(Chase, 2004). Neither is the proﬁle of neurotransmitter loss and cell
damage in PD as simple as in the 6OHDA midbrain lesioned rodent
(Halliday and McCann, 2009). In addition, the effect of recent surgery
should not be forgotten in the patient group. This is acknowledged to
lead to microlesional or stun effects that may temporarily attenuate
both beta synchrony and motor deﬁcit (Chen et al., 2006). Finally, it
should be stressed that the data used in our original rodent model
were recorded in anaesthetised animals, whereas patients were alert
during the recording.
Comparison with other basal ganglia models
Several computational studies have investigated the oscillatory na-
ture of activity in the basal ganglia network utilising forward models
(Gillies et al., 2002; Holgado et al., 2010; Humphries et al., 2006;
Leblois et al., 2006; Terman et al., 2002). Holgado et al. (2010), Gillies
et al. (2002) and Terman et al. (2002) modelled the STN–GPe circuit
and investigated changes that would occur in the network as synaptic
weights were varied to capture the difference between the physiologi-
cal and Parkinsonian state. In their seminal study, Holgado et al.
reported that the STN–GPe circuit is capable of generating beta oscilla-
tions when three conditions are met: (1) STN–GPe and GPe–STN con-
nections are strong enough, (2) excitation through the hyperdirect
pathway is stronger than striatal inhibition on GPe and (3) the time
required by neurons to react to their inputs needs to be short relative
to synaptic transmission delays. Our ﬁndings were broadly similar,
despite the fact that we considered a more extensive architecture
(containing the direct, hyper-direct and indirect pathways) and our
contrasts involved the change from the OFF drug to the ON drug state.
Additionally, we highlight the hyperdirect pathway as a core element
of the beta generating circuit, the former being given ﬁxed connection
strengths in the study of Holgado et al. (2010). Gillies et al. (2002)
and Terman et al. (2002) also studied the STN–GPe network using ﬁring
rate and a conductance based models, respectively. Gillies et al. found
recurrent connectivity within STN plays an important role in oscillation
generation. Such connectivity was not included by Holgado et al., nor in
the present study, as its existence is unclear (Hammond and Yelnik,
1983; Sato et al., 2000), and its incorporation does not seem essential
for the generation of oscillations in the beta frequency band. Terman
et al. (2002) reported that the STN–GPe network was capable of gener-
ating oscillations in the theta range, but their model did not include
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input from cortex to STN.
Humphries et al. (2006) used a spiking neuronmodel to study oscil-
latory activity in the cortico–basal ganglia network in the dopamine de-
pleted but anaesthetised state, which does not show beta oscillations
(Magill et al., 2001; Mallet et al., 2008b), and in the intact, alert animal,
where they found gamma activity. Leblois et al. (2006) included the
hyper-direct and direct circuits of the cortico–basal ganglia network in
their systems-level model and observed oscillations in the theta and
alpha frequency bands. This model might not have been able to gener-
ate oscillations in the beta band due to the absence of the indirect path-
way, which seems to be essential for the generation of oscillations at
these frequencies.
Thus a number of methodological differences exist between studies,
but the fundamental difference between the current and other model-
ing studies is the subject: we set out to contrast the pathophysiology
of ON and OFF medication states by ﬁtting our model to experimental
data derived frompatients rather than compare healthy and chronically
dopamine depleted states based on parameters drawn from studies in
non-humans (Gillies et al., 2002; Holgado et al., 2010; Humphries et
al., 2006; Kumar et al., 2011; Leblois et al., 2006; McCarthy et al.,
2011; Terman et al., 2002). Our goal was to derive a model that was of
clinical value and would allow exploration of the effects of candidate
therapeutic interventions through simulation, as demonstrated by our
mimicking of the effects of a STN lesion.We reasoned that amodel con-
volved with electrophysiological data from patients would have the
best chance of capturing the effects of the complex proﬁle of neuro-
transmitter loss and cell damage in PD and of any plastic changes due
to chronic intermittent dopaminergic therapy, in so far as these will
be expressed in the steady-state dynamics of the basal ganglia— cortical
circuit. Such factors are not captured in models that contrast the physi-
ological state with experimental Parkinsonism in non-humans. Never-
theless, despite these and the methodological differences discussed
above, many of these models, as ours, highlight the central role of the
STN–GPe circuit in the elaboration of pathological oscillations (Gillies
et al., 2002; Holgado et al., 2010; Humphries et al., 2006; Kumar et al.,
2011; Moran et al., 2011; Terman et al., 2002).
Limitations and future developments
We must emphasise several limitations of our approach. First, the
model presented here only provides a description of network dynamics
that might subtend beta oscillations in the basal ganglia–cortical loop,
predicated on the idea that these oscillations are important in elaborat-
ing the bradykinetic-rigid phenotype (Hammond et al., 2007; Jenkinson
and Brown, 2011). Accordingly, we cannot comment on whether
changes in connections might be important in sustaining other
non-oscillatory or oscillatory activities, such as tremor.
Second, we should stress that connectivity changes were not entire-
ly consistent between patients. Those considered here were signiﬁcant
in at least 50% of cases. Thus we may have overlooked meaningful
variation in circuit characteristics. In the future, it will be important to
deﬁne any relationship between less consistent changes in connectivity
and either slight variations in surgical targeting or clinical phenotype in
a study with larger numbers of patients.
Third, projections from the thalamus to the STN and globus pallidus
and those between these latter sites and the pedunculopontine nucleus
are likely to be important and were omitted from our model architec-
ture. This should be addressed in future iterations using Bayesian
model comparison, if and when simultaneous recordings of activities
at these sites become available in patients.
Fourth, we did not allow neural mass model (synaptic) parameters
to change between the ON and OFF levodopa conditions. In other
words, we constrained the effect of levodopa to be exerted through
changes in extrinsic coupling. This provided a parsimonious (efﬁcient)
model of the changes that was sufﬁcient to answer our questions. Inthe future it would be interesting to consider an extended model
space and test for differences in the intrinsic properties of the neuronal
populations (although our initial analyses along these lines were con-
founded by convergence problems that sometimes attend over
parameterised models).
In perspective
Our analyses lead to a new view of connectivity in the basal ganglia–
thalamocortical circuit, which acknowledges the importance of syn-
chrony in the pathophysiology of Parkinson's disease. Our scheme
makes strong and testable inferences about which projections have al-
tered strategic importance in thepathological state and offer themselves
as candidate therapeutic targets. Key amongst these strategically impor-
tant connections are those to and from the STN. Of note, however, was
that although the STN-GPe recurrent circuit may be an essential resona-
tor in the Parkinsonian system, it still requires some degree of input
through the hyperdirect pathway to operate in this mode. Finally, the
approach developed here can be extended to other complex neural
circuits, thereby allowing the exploration of the effects of candidate
therapeutic interventions through tractable, safe, cheap, but valid
simulations.
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